Letrozole in Preventing Breast Cancer in Postmenopausal Women With a BRCA1 or BRCA2 Mutation

Update l'année dernière
Reference: NCT00673335

Woman Man

  • | Country :
  • France
  • | organs :
  • -
  • | Specialty :
  • -

Extract

RATIONALE: Letrozole may prevent breast cancer in postmenopausal women with a BRCA1 or BRCA2 mutation. PURPOSE: This randomized phase III trial is studying letrozole to see how well it works compared with a placebo in preventing breast cancer in postmenopausal women with a BRCA1 or BRCA2 mutation.


Inclusion criteria

  • BRCA1 Mutation Carrier ,BRCA2 Mutation Carrier ,Breast Cancer ,Hereditary Breast/Ovarian Cancer (brca1, brca2)

Links